AzurRx BioPharma jumps 18% over formulation trial for treatment of COVID-19-associated gastrointestinal infections
10 February 2021 - 1:02AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AzurRx BioPharma (NASDAQ:AZRX)
Historical Stock Chart
From Apr 2024 to May 2024
AzurRx BioPharma (NASDAQ:AZRX)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about AzurRx BioPharma Inc (NASDAQ): 0 recent articles
More AzurRx BioPharma Inc News Articles